SCHEMBL18895909

SCHEMBL18895909

CC1(C)CN(CC/C=C2/c3ccccc3OCc3ncccc32)CCC1(O)c1ccc(Cl)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 14/20 0.80
▸ CHRM2 P08172 2/20 0.52
▸ CCR5 P51681 1/20 0.52
▸ HTR2B P41595 3/20 0.37
▸ HRH1 P35367 3/20 0.33
▸ KCNH2 Q12809 2/20 0.33
▸ SLC22A1 O15245 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ DRD5 P21918 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL652012 0.91 CCR1 (0.81) CCR1CHRM2CCR5HTR2BHRH1
SCHEMBL4341062 0.91 CCR1 (0.81) CCR1CHRM2CCR5HTR2BHRH1
SCHEMBL4341064 0.91 CCR1 (0.81) CCR1CHRM2CCR5HTR2BHRH1
SCHEMBL18776061 0.91 CCR1 (0.81) CCR1CHRM2CCR5HTR2BHRH1
SCHEMBL652013 0.91 CCR1 (0.81) CCR1CHRM2CCR5HTR2BHRH1
SCHEMBL653494 0.89 CCR1 (1.00) CCR1CHRM2CCR5HRH1
SCHEMBL438487 0.89 CCR1 (1.00) CCR1CHRM2CCR5HRH1
SCHEMBL656424 0.89 CCR1 (0.77) CCR1CHRM2CCR5HRH1
SCHEMBL438265 0.89 CCR1 (1.00) CCR1CHRM2CCR5HRH1
SCHEMBL2197331 0.89 CCR1 (0.77) CCR1CHRM2CCR5HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
Send feedback